Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice

Autoimmunity

Volumn 46, Issue 3, 2013, Pages 188-204

  Clark, Amy G ^a,b   Fan, Qihua ^a,b   Brady, Graham F ^a,b   MacKin, Katherine M ^a,b   Coffman, Evan D ^a,b   Weston, Melissa L ^a,b   Foster, Mary H ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Deletion; Laminin; Tolerance; Transgenic mice

Indexed keywords

ALLOTYPE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BASEMENT MEMBRANE; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CROSS LINKING; DNA MODIFICATION; FEMALE; HEAVY CHAIN; HUMORAL IMMUNE DEFICIENCY; HYBRIDOMA; IMMUNOLOGICAL TOLERANCE; LUPUS VULGARIS; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; PHENOTYPE; SECRETORY CELL; SPLEEN CELL; TRANSGENIC MOUSE; TURNOVER TIME;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; BASE SEQUENCE; BONE MARROW CELLS; CD4-CD8 RATIO; FEMALE; IMMUNE TOLERANCE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; LAMININ; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NZB; MICE, TRANSGENIC; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 84876273195     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.746671     Document Type: Article

References (73)

1. Harley, I. T., K. M. Kaufman, C. D. Langefeld, J. B. Harley, and J. A. Kelly. 2009. Genetic susceptibility to SLE: New insights from fine mapping and genome-wide association studies. Nat. Rev. Genetics 10(5): 285-290.
2. Ramos, P. S., E. E. Brown, R. P. Kimberly, and C. D. Langefeld. 2010. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin. Nephrol. 30(2): 164-176.
3. Kono, D. H., and A. N. Theofilopoulos. 2006. Genetics of SLE in mice. Springer Semin. Immunopathol. 28(2): 83-96.
4. Morel, L. 2010. Genetics of SLE: evidence from mouse models. Nat. Rev. Rheumatol. 6: 348-357.
5. Pathak, S., and C. Mohan. 2011. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res. Ther. 13(5): 241.
6. Kyogoku, C., C. D. Langefeld, W. A. Ortmann, et al. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75(3): 504-507.
7. Kozyrev, S. V., A. K. Abelson, J. Wojcik, et al. 2008. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40(2): 211-216.
8. Cunninghame Graham, D. S., R. R. Graham, H. Manku, et al. 2008. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat. Genet. 40(1): 83-89.
9. Gateva, V., J. K. Sandling, G. Hom, et al. 2009. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41(11): 1228-1233.
10. Cunninghame Graham, D. S., D. L. Morris, T. R. Bhangale, et al. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7(10): e1002341.
11. Zhou, X. J., X. L. Lu, S. K. Nath, et al. 2012. Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus. Arthritis Rheum. 64(1): 222-231.
12. Chung, S. A., K. E. Taylor, R. R. Graham, et al. 2011. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet. 7(3): e1001323, Epub 2011/03/17.
13. Hall, S. W., and A. Cooke. 2011. Autoimmunity and inflammation: murine models and translational studies. Mammal. Genome J. Inter. Mammal. Genome Soc. 22(7-8): 377-389, Epub 2011/06/19. doi: 10.1007/s00335- 011-9338-2.
14. Sabbaga, J., S. R. P. Line, P. Potocnjak, and M. P. Madaio. 1989. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major noncollagenous protein component of the glomerular basement membrane. Eur. J. Immunol. 19: 137-143.
15. Foster, M. H., J. Sabbaga, S. R. P. Line, et al. 1993. Molecular analysis of nephrotropic anti-laminin antibodies from an MRL/lpr autoimmune mouse. J. Immunol. 151: 814-824.
16. Ben-Yehuda, A., L. Rasooly, R. Bar-Tana, et al. 1995. The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J. Autoimmun. 8: 279-291.
17. Amital, H., M. Heilweil, R. Ulmansky, et al. 2005. Treatment with a laminin-derived peptide suppresses lupus nephritis. J. Immunol. 175(8): 5516-5523.
18. Amital, H., M. Heilweil-Harel, R. Ulmansky, et al. 2007. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford) 46(9): 1433-1437.
19. Li, Q. Z., C. Xie, T. Wu, et al. 2005. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 115(12): 3428-3439.
20. Fitzsimons,M.M., H. Chen, and M. H. Foster. 2000. Diverse endogenous light chains contribute to basement membrane reactivity in nonautoimmune mice transgenic for an antilaminin Ig heavy chain. Immunogenetics 51: 20-29.
21. Rudolph, E. H., K. L. Congdon, F. N. Sackey, M. M. Fitzsimons, and M. H. Foster. 2002. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptors. J. Immunol. 168: 5943-5953.
22. Brady, G. F., K. L. Congdon, A. G. Clark, et al. 2004. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig. J. Immunol. 172(9): 5313-5321.
23. Clark, A. G., K.M. Mackin, and M. H. Foster. 2008. Tracking differential gene expression in MRL/MpJ versus C57BL/6 anergic B cells: Molecular markers of autiommunity. Biomarker Insights 3: 335-350.
24. Foster, M. H., and M. M. Fitzsimons. 1998. Lupus-like nephrotropic autoantibodies in nonautoimmune mice harboring an anti-basement membrane/anti-DNA Ig heavy chain transgene. Mol. Immunol. 35: 83-94.
25. Clark, A. G., K.M.Mackin, and M. H. Foster. 2011. Genetic elimination of alpha3(IV) collagen fails to rescue anti-collagen B cells. Immunol. Lett. 141(1): 134-139.
26. Oi, V., S. L. Morrison, L. A. Herzenberg, and P. Berg. 1983. Immunglobulin gene expression in transformed lymphoid cells. Proc. Natl. Acad. Sci. USA 80: 825-829.
27. Tybulewicz, V. L. J., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153-1163.
28. Brochet, X., M.-P. Lefranc, and V. Giudicelli. 2008. IMGT/ V-Quest: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucl. Acids Res. 36: W503-W508, doi: 10.1093.
29. Foster, M. H., B. G. Cooperstone, and H. Chen. 1998. Antiidiotypic monoclonal Ig specific for an anti-laminin Ig heavy chain transgene variable region. Hybridoma 17(4): 323-329.
30. Amano, H., E. Amano, T.Moll, et al. 2003. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J. Immunol. 170(5): 2293-2301.
31. Moll, T., E. Martinez-Soria, M.-L. Santiago-Raber, et al. 2005. Differential activation of anti-erythrocyte and anti-DNA autoreactive B lymphocytes by the Yaa mutation. J. Immunol. 174: 702-709.
32. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, et al. 2006. Difilippantonio et al. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312(5780): 1669-1672.
33. Subramanian, S., K. Tus, Q. Z. Li, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103(26): 9970-9975.
34. Santiago-Raber, M.-L., S. Kikuchi, P. Borel, et al. 2008. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J. Immunol. 181: 1556-1562.
35. Meffre, E. 2011. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann. NY Acad. Sci. 1246(1): 1-10.
36. Isnardi, I., Y. S. Ng, I. Srdanovic, et al. 2008. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29(5): 746-757.
37. Meyers, G., Y. S. Ng, J. M. Bannock, et al. 2011. Activationinduced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl. Acad. Sci. USA 108(28): 11554-11559.
38. Kuraoka, M., T. M. Holl, D. Liao, et al. 2011. Activationinduced cytidine deaminase mediates central tolerance in B cells. Proceedings of the Natl. Acad. USA 108(28): 11560-11565.
39. Menard, L., D. Saadoun, I. Isnardi, et al. 2011. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 121(9): 3635-3644.
40. Murakami, M., T. Tsubata, M. Okamoto, et al. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357: 77-80.
41. Nisitani, S., T. Sakiyama, and T. Honjo. 1998. Involvement of IL-10 in induction of autoimmune hemolytic anemia in antierythrocyte Ig transgenic mice. Int. Immunol. 10(8): 1039-1047.
42. Goodnow, C. C., J. Crosbie, S. Adelstein, et al. 1988. Altered immunoglobulin expression and functional silencing of selfreactive B lymphocytes in transgenic mice. Nature 334: 676-682.
43. Chang, N.-H., Y.-H. Cheung, C. Loh, et al. 2010. B Cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One 5(7): e11691.
44. Santiago-Raber, M. L., H. Amano, E. Amano, et al. 2010. Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J. Autoimmun. 34(4): 349-355.
45. Bendelac, A., M. Bonneville, and J. F. Kearney. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1(3): 177-186.
46. Meyer-Bahlburg, A., and D. J. Rawlings. 2012. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front. Biosci. 17: 1499-1516.
47. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogeninduced lupus. J. Immunol. 167(4): 1886-1890.
48. Mackay, F., S. A. Woodcock, P. Lawton, et al. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190(11): 1697-1710.
49. Liu, Y., L. Li, K. R. Kumar, et al. 2007. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J. Immunol. 179(2): 1340-1352.
50. Duan, B., B. P. Croker, and L. Morel. 2007. Lupus resistance is associated with marginal zone abnormalities in an NZM murine model. Lab. Invest. J. Tech. Meth. Pathol. 87(1): 14-28.
51. Duan, B., H. Niu, Z. Xu, et al. 2008. Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab. Invest. 88(9): 1008-1020.
52. Shao,W. H., A. P. Kuan, C.Wang, et al. 2010. Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J. Autoimmun. 35(4): 368-374.
53. Zhou, Z., H. Niu, Y. Y. Zheng, and L. Morel. 2011. Autoreactive marginal zone B cells enter the follicles and interact with CD4 T cells in lupus-prone mice. BMC Immunol. 12: 7.
54. Wither, J. E., C. Loh, G. Lajoie, et al. 2005. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J. Immunol. 175(7): 4309-4319.
55. Foster, M. H., Y. Zhang, and A. G. Clark. 2006. Deconstructing B cell tolerance to basement membranes. Arch. Immunol. Ther. Exp. 54: 227-237.
56. Al-Qahtani, A., Z. Xu, H. Zan, C. M. Walsh, and P. Casali. 2008. A role for DRAK2 in the germinal center reaction and the antibody response. Autoimmunity 41(5): 341-352.
57. Wellmann, U., M. Letz, A. Schneider, K. Amann, and T. H. Winkler. 2001. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB £ NZW)F1 mice. Int. Immunol. 13(12): 1461-1469.
58. Jacob, N., and W. Stohl. 2010. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity 43(1): 84-97.
59. Roark, J. H., C. L. Kuntz, K. Nguyen, A. J. Caton, and J. Erikson. 1995. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181: 1157-1167.
60. Rubio, C. F., J. Kench, D. M. Russell, R. Yawger, and D. Nemazee. 1996. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J. Immunol. 157: 65-71.
61. Santulli-Marotto, S., Y. Qian, S. Ferguson, and S. H. Clarke. 2001. Anti-Sm B cell differentiation in Ig transgenic MRL/ Mp-lpr/lpr mice: Altered differentiation and an accelerated response. J. Immunol. 166(8): 5292-5299.
62. Chen, C., H. Li, Q. Tian, et al. 2006. Selection of anti-doublestranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol. 176(9): 5183-5190, PubMed PMID: 16621982.
63. Friedmann, D., N. Yachimovich, G. Mostoslavsky, et al. 1999. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol. 162: 4406-4416.
64. Wellmann, U., A. Werner, and T. H. Winkler. 2001. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur. J. Immunol. 31: 2800-2810.
65. Spatz, L., V. Saenko, A. Iliev, et al. 1997. Light chain usage in anti-double-stranded DNA B cell subsets: Role in cell fate determination. J. Exp. Med. 185: 1317-1326.
66. Steeves, M. A., and T. N. Marion. 2004. Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene. J. Immunol. 172(11): 6568-6577.
67. Duong, B. H., T. Ota, D. Ait-Azzouzene, et al. 2010. Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen. J. Immunol. 184(8): 4143-4158.
68. Roes, J., and K. Rajewsky. 1993. Immunoglobulin D (IgD)- deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J. Exper. Med. 177(1): 45-55.
69. Nitschke, L., M. H. Kosco, G. Kohler, and M. C. Lamers. 1993. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc. Natl. Acad. Sci. USA 90(5): 1887-1891.
70. Woodward, E. J., and J. W. Thomas. 2005. Multiple germline kappa light chains generate anti-insulin B cells in nonobese diabetic mice. J. Immunol. 175(2): 1073-1079.
71. Henry, R. A., P. L. Kendall, E. J. Woodward, C. Hulbert, and J.W. Thomas. 2010. Vkappa polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strains. Immunogenetics 62(8): 507-520.
72. W. Trepicchio, Jr., and K. J. Barrett. 1985. The Igh-V locus of MRL mice: Restriction fragment length polymorphism in eleven strains of mice as determined with VH and D gene probes. J. Immunol. 134: 2734-2739.
73. Kompfner, E., P. Oliveira, A. Montalbano, and A. J. Feeney. 2001. Unusual germline DSP2 gene accounts for all apparent V-D-D-J rearrangements in newborn, but not adult, MRL mice. J. Immunol. 167(12): 6933-6938.